Status:

COMPLETED

Evaluating the Benefits of Physiologic Insulin Delivery

Lead Sponsor:

Stanford University

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Type 1 Diabetes

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

Brief Summary

In normal physiology insulin is secreted by beta cells into the portal vein. There have been a number of purported benefits among long-term intraperitoneal insulin users. In the present study we will ...

Detailed Description

The eventual goal of this line of work is an implanted insulin pump that delivers insulin automatically into the peritoneum based on continuous glucose data. All prior intraperitoneal pharmacokinetic ...

Eligibility Criteria

Inclusion

  • 18-60 years of age
  • Clinical diagnosis of type 1 diabetes
  • On insulin pump therapy and continuous glucose monitor (CGM) for at least 3 months
  • Ability to safely receive intraperitoneal injection
  • For females, not currently known to be pregnant
  • Understanding and willingness to follow the protocol and sign informed consent
  • Ability to speak, read and write in the language of the investigators

Exclusion

  • Diabetic ketoacidosis in the past 3 months
  • Severe hypoglycemia resulting in seizure or loss of consciousness within 3 months prior to enrollment
  • Pregnant or lactating
  • Active infection
  • A known medical condition that in the judgment of the investigator might interfere with the completion of the protocol
  • Known cardiovascular events in the last 6 months
  • Known seizure disorder
  • Inpatient psychiatric treatment in the past 6 months
  • Lack of stability on medication 1 month prior to enrollment including antihypertensive, thyroid, anti-depressant or lipid lowering medication.
  • Suspected drug or alcohol abuse
  • Chronic kidney disease (GFR \< 60 mL/min/1.73m\^2)

Key Trial Info

Start Date :

November 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 2 2023

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT04416737

Start Date

November 1 2021

End Date

June 2 2023

Last Update

October 1 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford University

Stanford, California, United States, 94304

Evaluating the Benefits of Physiologic Insulin Delivery | DecenTrialz